6550--Optilite analyzer reagents
Key Dates
Due Date
-
Posted Date
-
Agency & Value
Agency
262-NETWORK CONTRACT OFFICE 22 (36C262)
Contract Value
Not provided
Codes & Classification
Solicitation Number
36C26227Q0052
NAICS
325413 - In-Vitro Diagnostic Substance Manufacturing
Classification Code
6550
Additional Details
Documents1
The Department of Veterans Affairs, through its 262-Network Contract Office 22, has issued an award notice for the procurement of Optilite analyzer reagents. This acquisition falls under NAICS code 325413, which pertains to In-Vitro Diagnostic Substance Manufacturing, and is classified with product service code 6550. The primary objective of this procurement is to secure specialized reagents compatible with Optilite analyzers, supporting the ongoing diagnostic and laboratory needs within VA medical facilities.
The scope of this contract encompasses the supply of high-quality in-vitro diagnostic reagents, which are essential for the accurate operation of Optilite analyzers. These reagents are critical for conducting a range of diagnostic tests, thereby contributing to the effective healthcare delivery for veterans. The intended outcome is to ensure uninterrupted access to reliable diagnostic substances, maintaining the operational readiness of laboratory equipment and supporting clinical decision-making.
The contracting entity responsible for this procurement is the 262-Network Contract Office 22, a federal office within the Department of Veterans Affairs. The office is tasked with managing contracts that directly impact the health and well-being of veterans served by VA facilities. The primary point of contact for this notice is Carlos Magana, who can be reached via email at [email protected] or by phone at 562-766-2253 for any inquiries related to the award.
This procurement is an award notice, indicating that the contract has already been granted. Contractors interested in similar opportunities should note that the requirement is for in-vitro diagnostic substances specifically designed for Optilite analyzers, and must comply with the relevant manufacturing standards as outlined in NAICS 325413. The notice remains active and is accessible through the SAM.gov portal, with further details and attachments available via the provided URL.
No set-aside requirements or special considerations are specified in the notice. The contract is expected to deliver consistent, high-quality reagents throughout its lifecycle, ensuring that VA laboratories are equipped to meet their diagnostic obligations. Contractors evaluating their alignment with this opportunity should consider their capacity to manufacture and supply in-vitro diagnostic substances that meet the stringent requirements of federal healthcare facilities.
For additional information, reference SAM.gov Opportunity ID 55cef14ad8e2492e92baed07d2db6db2 or visit the notice URL. The procurement identifier for this award is 36C26227Q0052.